University of Colorado, Denver
The purpose of this study is to determine if non-steroidal anti-inflammatory (NSAID) use in the postoperative setting increases the risk of acute kidney injury (AKI) in pediatric patients with mild-to-moderate chronic kidney disease (CKD). The investigators hypothesize that there is no increased risk. This is currently in the process of developing multi institution collaboration within a Pediatric Urology population, intended to inform future work in a larger patient population.
Inclusion Criteria: * Patients over 18 months of age * diagnosis of CKD stages 2-3a, confirmed by CKiD U25 eGFR calculator based on cystatin C laboratory testing within 6 months of surgery * Patient is scheduled to undergo a urologic surgery requiring admission or overnight stay in the hospital Exclusion Criteria: * Diagnosis of CKD stage 1 or 4-5 * Past medical history of renal transplant * Past medical history of nasal polyp * Procedure for oncologic indications or on chemotherapy * Pregnant patient * True allergy to NSAIDs
IV formulation: ketorolac 0.5mg/kg/dose, 15mg maximum, no more than 8 doses total PO formulation: ibuprofen suspension 10mg/kg/dose, 400mg maximum Total duration (IV + PO) will not exceed 5 days.
IV or PO medication, compounded to have similar look, consistency and taste to the corresponding medications
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.